Predictive role of P-wave axis abnormalities in secondary cardiovascular prevention

Abstract

Background

Abnormal P-wave axis has been correlated with an increased risk of all-cause and cardiovascular mortality in a general population. We aimed to evaluate the prognostic role of abnormal P-wave axis in patients undergoing myocardial revascularisation or cardiac valve surgery.

Methods

We considered data of 810 patients with available P-wave axis measure from a prospective monocentric registry of patients undergoing cardiovascular rehabilitation. A total of 436 patients (54%) underwent myocardial revascularisation, 253 (31%) valve surgery, 71 (9%) combined valve and coronary artery bypass graft surgery and 50 (6%) cardiac surgery for other cardiovascular disease. Mean follow-up was 47 ± 27 months.

Results

Over the whole group, P-wave axis was 43.8° ± 27.5° and an abnormal P-wave axis was found in 94 patients (12%). The risk of overall (hazard ratio (HR) 2.5, 95% confidence interval (CI) 1.6–4.0, P < 0.001) and cardiovascular mortality (HR 2.9, 95% CI 1.5–5.8, P = 0.002) was significantly higher in patients with abnormal P-wave axis even after adjustment for age, other electrocardiographic variables (PR, QRS, QTc intervals), left ventricular ejection fraction and left atrial volume index. After dividing the population according to the type of disease, patients with abnormal P-wave axis and ischaemic heart disease had 3.9-fold higher risk of cardiovascular mortality (HR 3.9, 95% CI 1.3–12.1, P = 0.017), while a 2.2-fold higher risk of cardiovascular mortality (HR 3.6, 95% CI 1.3–10.1, P = 0.015) was found in those with cardiac valve disease.

Conclusion

An abnormal P-wave axis represents an independent predictor of both overall and cardiovascular mortality in patients undergoing myocardial revascularisation or cardiac valve surgery.

Keywords

P-wave axis cardiovascular prevention ischaemic heart disease cardiac valve disease prognostic role cardiac surgery

Get full access to this article

View all access options for this article.

References

Shah

Soliman

. Effect of electrocardiographic P-wave axis on mortality. Am J Cardiol 2014; 113: 372–376.

Perez

Dewey

Marcus

et al.

Electrocardiographic predictors of atrial fibrillation. Am Heart J 2009; 158: 622–628.

Rangel

O’Neal

Soliman

. Usefulness of the electrocardiographic P-wave axis as a predictor of atrial fibrillation. Am J Cardiol 2016; 117: 100–104.

Mezzani

Hamm

Jones

et al.

Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation. Eur J Prev Cardiol 2013; 20: 442–467.

Smith

O’Neal

Shoemaker

et al.

PR-interval components and atrial fibrillation risk (from the Atherosclerosis Risk in Communities Study). Am J Cardiol 2017; 119: 466–472.

Magnani

Johnson

Sullivan

et al.

P wave duration and risk of longitudinal atrial fibrillation in persons ≥60 years old (from the Framingham Heart Study). Am J Cardiol 2011; 107: 917–921.

Bayés de Luna

Baranchuk

Escobar Robledo

et al.

Diagnosis of interatrial block. J Geriatr Cardiol 2017; 14: 161–165.

Boriani

Diemberger

Camanini

et al.

P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. Int J Cardiol 2005; 101: 355–361.

Lazzeroni

Parati

Bini

et al.

P-wave dispersion predicts atrial fibrillation following cardiac surgery. Int J Cardiol 2016; 203: 131–133.

10.

Kaykha

Myers

Desser

et al.

The prognostic importance of isolated P-wave abnormalities. Clin Cardiol 2010; 33: E87–E93.

11.

Rasmussen

Nielsen

Skov

et al.

Electrocardiographic PR interval duration and cardiovascular risk: results from the Copenhagen ECG study. Can J Cardiol 2017; 33: 674–681.

12.

Crisel

Farzaneh-Far

et al.

First-degree atrioventricular block is associated with heart failure and death in persons with stable coronary artery disease: data from the Heart and Soul Study. Eur Heart J 2011; 32: 1875–1880.

13.

Bombelli

Facchetti

Cuspidi

et al.

Prognostic significance of left atrial enlargement in a general population. Results of the PAMELA study. Hypertension 2014; 64: 1205–1211.

14.

Lazzeroni

Gaibazzi

Bini

et al.

Prognostic value of new left atrial volume index severity partition cutoffs after cardiac rehabilitation program in patients undergoing cardiac surgery. Cardiovasc Ultrasound 2016; 14: 35–41.

15.

Kizer

Bella

Palmieri

et al.

Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 2006; 151: 412–418.

16.

Chhabra

Sareen

Perli

et al.

Vertical P-wave axis: the electrocardiographic synonym for pulmonary emphysema and its severity. Indian Heart J 2012; 64: 40–42.

17.

Spodick

. Electrocardiographic studies in pulmonary disease: electrocardiographic abnormalities in diffuse lung disease. Circulation 1959; 20: 1067–1072.

18.

Thomas

Apiyasawat

Spodick

. Electrocardiographic detection of emphysema. Am J Cardiol 2011; 107: 1090–1092.

19.

Piepoli

Hoes

Agewall

et al.

2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur J Prev Cardiol 2016; 23: NP1–NP96.